出典:Wikipedia
出典:『Wikipedia』 (2011/07/16 12:44 UTC 版)
Belimumab (trade name Benlysta, previously known as LymphoStat-B), is a fully human monoclonal antibody that inhibits B-lymphocyte stimulator (BLyS), also known as B cell activation factor of the TNF family (BAFF). It is approved in the U.S., Canada and Europe for treatment of systemic lupus erythmatosis (SLE), and is under investigation for use in other autoimmune diseases.